| Osayawe Nosayaba Odeh, MD | |
|
620 Skyline Dr, Jackson, TN 38301-3923 | |
| (731) 541-8154 | |
| (731) 541-6068 |
| Full Name | Osayawe Nosayaba Odeh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 620 Skyline Dr, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245255819 | NPI | - | NPPES |
| 3815661 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 54045 (Kentucky) | Secondary |
| 207R00000X | Internal Medicine | 41414 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intrepid Usa Healthcare Services | Jackson, TN | Home health agency |
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| Baptist Health Madisonville | Madisonville, KY | Hospital |
| Jackson Purchase Medical Center | Mayfield, KY | Hospital |
| T J Samson Community Hospital | Glasgow, KY | Hospital |
| Lincoln Medical Center | Fayetteville, TN | Hospital |
| Ahc West Tennessee Transitional Care | Jackson, TN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jackson Clinic Pa | 2668376872 | 176 |
| Hospital Medicine Services Of Tennessee Pc | 9234432881 | 140 |
| Southeastern Physician Services Pc | 0042307852 | 473 |
| Hospital Medicine Services Of Tennessee Pc | 9234432881 | 140 |
News Archive
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.
The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.
According to a study published in the Lancet on Saturday, researchers from the University of Pelotas in Brazil tracking progress toward the Millennium Development Goals (MDGs) 4 and 5 - which promote maternal and child health - "discovered that the most equitable intervention was early initiation of breastfeeding, and that the attendance of a skilled person at birth proved to be the least equitable intervention," Medical News Today reports.
On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.
› Verified 6 days ago
| Entity Name | Jackson Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285629386 PECOS PAC ID: 2668376872 Enrollment ID: O20040318000962 |
News Archive
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.
The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.
According to a study published in the Lancet on Saturday, researchers from the University of Pelotas in Brazil tracking progress toward the Millennium Development Goals (MDGs) 4 and 5 - which promote maternal and child health - "discovered that the most equitable intervention was early initiation of breastfeeding, and that the attendance of a skilled person at birth proved to be the least equitable intervention," Medical News Today reports.
On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.
› Verified 6 days ago
| Entity Name | App Of Tennessee Hm, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396160768 PECOS PAC ID: 5395960694 Enrollment ID: O20140630001088 |
News Archive
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.
The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.
According to a study published in the Lancet on Saturday, researchers from the University of Pelotas in Brazil tracking progress toward the Millennium Development Goals (MDGs) 4 and 5 - which promote maternal and child health - "discovered that the most equitable intervention was early initiation of breastfeeding, and that the attendance of a skilled person at birth proved to be the least equitable intervention," Medical News Today reports.
On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.
› Verified 6 days ago
| Entity Name | Hospital Medicine Services Of Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528433802 PECOS PAC ID: 9234432881 Enrollment ID: O20160114002673 |
News Archive
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.
The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.
According to a study published in the Lancet on Saturday, researchers from the University of Pelotas in Brazil tracking progress toward the Millennium Development Goals (MDGs) 4 and 5 - which promote maternal and child health - "discovered that the most equitable intervention was early initiation of breastfeeding, and that the attendance of a skilled person at birth proved to be the least equitable intervention," Medical News Today reports.
On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.
› Verified 6 days ago
| Entity Name | Hospital Medicine Services Of Tn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982301065 PECOS PAC ID: 2365807633 Enrollment ID: O20230421000177 |
News Archive
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.
The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.
According to a study published in the Lancet on Saturday, researchers from the University of Pelotas in Brazil tracking progress toward the Millennium Development Goals (MDGs) 4 and 5 - which promote maternal and child health - "discovered that the most equitable intervention was early initiation of breastfeeding, and that the attendance of a skilled person at birth proved to be the least equitable intervention," Medical News Today reports.
On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Osayawe Nosayaba Odeh, MD Po Box 400, Jackson, TN 38302-0400 Ph: (731) 423-8697 | Osayawe Nosayaba Odeh, MD 620 Skyline Dr, Jackson, TN 38301-3923 Ph: (731) 541-8154 |
News Archive
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.
The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.
According to a study published in the Lancet on Saturday, researchers from the University of Pelotas in Brazil tracking progress toward the Millennium Development Goals (MDGs) 4 and 5 - which promote maternal and child health - "discovered that the most equitable intervention was early initiation of breastfeeding, and that the attendance of a skilled person at birth proved to be the least equitable intervention," Medical News Today reports.
On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.
› Verified 6 days ago
John Baker, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 587 Skyline Dr, Jackson, TN 38301 Phone: 731-421-6510 Fax: 731-421-6500 | |
Dr. Susan Alex, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 Sterling Farms Dr., Jackson, TN 38305 Phone: 731-668-4337 Fax: 731-661-0124 | |
Dr. Kelsey B Dexter, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-660-8336 | |
Kpienoba Manan Hien, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-5000 | |
Lucas Carver, Internal Medicine Medicare: Medicare Enrolled Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-5000 | |
Dr. Clyde E Smith, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 27 Medical Center Dr, Jackson, TN 38301 Phone: 731-424-1001 | |
Brittain Douglas Little, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 27 Medical Center Dr, Jackson, TN 38301 Phone: 731-424-1001 Fax: 731-426-0388 |